PULSE BIOSCIENCES, INC. — Director's Dealing 2023

Jul 15, 2023

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: Pulse Biosciences, Inc. (PLSE)
CIK: 0001625101
Period of Report: 2023-07-12

Reporting Person: Danahy Kevin Patrick (Chief Executive Officer)

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2023-07-12	Stock Option (right to buy)	$7.08	A	200000	Acquired	2033-07-12	Common Stock (200000)	Direct

Footnotes

F1: The option was granted on July 12, 2023 under the Issuer's 2017 Equity Incentive Plan. The shares subject to the option are subject to two tranches of performance-based vesting criteria tied to Issuer's market capitalization, with no vesting until the Issuer's market capitalization exceeds $4 billion, in both cases, subject to the Reporting Person's continued service through each vesting milestone.

F2: Not applicable.